A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients with Peripheral TCell Lymphoma | Azienda Ospedaliero - Universitaria SS. Antonio e Biagio e Cesare Arrigo - Alessandria

A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients with Peripheral TCell Lymphoma

Promotore: Acrotech Biopharma Inc

Acronimo: SPI-BEL-301

Struttura: Ematologia

Sperimentatore principale: Zanni Manuela

Stato arruolamento: In attesa di arruolamento

Linee di ricerca: Linfoma non Hodgkin